Series:

On the Surface: A Literature Review

Review the latest dry eye literature

Analyzing the Causes of Neuropathic Corneal Pain

Show Description +

Laura Periman, MD, welcomes Tufts University professor, Pedram Hamrah, MD, to discuss his recent clinical paper reviewing patients with neuropathic corneal pain and their response to low-dose naltrexone. In the first part of this two-part interview, Dr. Hamrah examines the leading causes of centralized neuropathic pain, such as anxiety, depression, and small fiber neuropathy.

REFERENCES
Dieckmann G, Ozmen MC, Cox SM, Engert RC, Hamrah P. Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain. Ocul Surf. 2021 Apr;20:33-38. doi: 10.1016/j.jtos.2020.12.003. Epub 2021 Jan 12. PMID: 33450415.

Posted: 8/27/2021

Up Next

The Link Between Dry Eye, Migraine Headache Disorder, and Ocular Pain

Laura M. Periman, MD; and Anat Galor, MD, MSPH


New Methods for Analyzing and Treating Neuropathic Ocular Pain

Laura M. Periman, MD; and Anat Galor, MD, MSPH

The Effects of Neurostimulation on Dry Eye Disease

Laura M. Periman, MD; and Vance Thompson, MD, FACS

The Influence of Dry Eye Disease on Overall Quality of Life

Laura M. Periman, MD, Scott Schachter, OD

Prevalence of Dry Eye Disease in Sleep Apnea Sufferers

Cynthia Matossian, MD, Laura M. Periman, MD

The Role of Screen Time in Dry Eye Disease

Josh Johnston, OD, FAAO, Laura M. Periman, MD

The Intersection of Dry Eye and Glaucoma

Inder Paul Singh, MD, Laura M. Periman, MD

Dry Eye Considerations in the Preoperative Surgical Patient

Christopher E. Starr, MD, FACS, Laura M. Periman, MD

Low-Level Light Therapies

Laura M. Periman, MD; and Darrell E. White, MD

Pulsed Light Patterns and Meibomian Gland Dysfunction

Laura M. Periman, MD; and Darrell E. White, MD

Hyperkeratinization in Meibomian Gland Dysfunction

Laura M. Periman, MD; and John A. Hovanesian, MD, FACS

Treating Neuropathic Corneal Pain With Low-Dose Naltrexone

Laura M. Periman, MD; and Pedram Hamrah, MD

Analyzing the Causes of Neuropathic Corneal Pain

Laura Periman, MD, welcomes Tufts University professor, Pedram Hamrah, MD, to discuss his recent clinical paper reviewing patients with neuropathic corneal pain and their response to low-dose naltrexone. In the first part of this two-part interview, Dr. Hamrah examines the leading causes of centralized neuropathic pain, such as anxiety, depression, and small fiber neuropathy.

REFERENCES
Dieckmann G, Ozmen MC, Cox SM, Engert RC, Hamrah P. Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain. Ocul Surf. 2021 Apr;20:33-38. doi: 10.1016/j.jtos.2020.12.003. Epub 2021 Jan 12. PMID: 33450415.

Posted: 8/27/2021


Please log in to leave a comment.